CARDIOVASCULAR MEDICINE

Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation

E Hyodo, T Hozumi, Y Takemoto, H Watanabe, T Muro, H Yamagishi, M Yoshiyama, K Takeuchi, J Yoshikawa

Department of Internal Medicine and Cardiology, Osaka City University School of Medicine, Osaka, Japan

Correspondence to:
Correspondence to:
Dr T Hozumi
Department of Internal Medicine and Cardiology, Osaka City University School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, Japan, 545-8585; thozumi{at}med.osaka-cu.ac.jp

Objectives: To clarify the value of cycle dependent variation of myocardial integrated backscatter (CV-IB) analysis, which non-invasively measures acoustic properties of the myocardium, for early detection of cardiac involvement in patients with sarcoidosis.

Methods: The study population consisted of 22 consecutive patients with biopsy proven sarcoidosis who did not have any abnormal findings on conventional two dimensional echocardiogram. Cardiac sarcoidosis was diagnosed by radionuclide testing including thallium-201 scintigraphy, gallium-67 scintigraphy, and cardiac fluorine-18-deoxyglucose positron emission tomography. The magnitude and delay of the CV-IB were analysed in the basal mid septum and the basal mid posterior wall of the left ventricle of all patients.

Results: The patients were divided into two groups: 8 patients with cardiac involvement and 14 patients without cardiac involvement. In the basal septum, a major reduction in the magnitude (mean (SD) 1.8 (4.4) v 6.6 (1.3), p = 0.012) and an increase in the time delay (1.3 (0.5) v 1.0 (0.1), p = 0.038) of CV-IB were observed in patients with cardiac sarcoidosis even in the absence of two dimensional echocardiographic abnormalities. The sensitivity for detecting cardiac involvement was such that the magnitude of CV-IB in the basal septum discriminated 75% of patients with cardiac sarcoidosis from those with non-cardiac sarcoidosis, whereas two dimensional echocardiographic parameters did not discriminate between these two groups.

Conclusions: The CV-IB is decreased in the basal septum in patients with cardiac sarcoidosis even in the absence of two dimensional echocardiographic abnormalities. Analysis of CV-IB may be a useful method to detect early myocardial involvement in patients with sarcoidosis.

Abbreviations: ¹⁸FDG PET, fluorine-18-deoxyglucose positron emission tomography; IB, integrated backscatter; CV-IB, cycle dependent variation of myocardial integrated backscatter

Keywords: sarcoidosis; ultrasonics; echocardiography

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Ichinose, A., Otani, H., Oikawa, M., Takase, K., Saito, H., Shimokawa, H., Takahashi, S. (2008). MRI of Cardiac Sarcoidosis: Basal and Subepicardial Localization of Myocardial Lesions and Their Effect on Left Ventricular Function. Am. J. Roentgenol. 191: 862-869 [Abstract] [Full Text]  
• Pandya, C., Brunken, R. C., Tchou, P., Schoenhagen, P., Culver, D. A. (2007). Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques. Eur Respir J 29: 418-422 [Abstract] [Full Text]  
• Judson, M. A. (2005). Cardiac Sarcoidosis: There Is No Instant Replay. Chest 128: 3-6 [Full Text]